Dotmatics aims to speed drug development, break data silos with Geneious Luma
Even as enterprises across sectors explore how to integrate generative AI, it’s clear that biomedical research and the sciences are among the areas that could benefit most — as highlighted in the recent Nobel Prizes in Chemistry and Physics awarded to AI researchers.
Now Dotmatics, a leader in research and development scientific software, wants to give drug researchers the power of AI to speed up their development of new, life-saving and improving drugs.
Today, the Boston-based company launches Geneious Luma, a powerful new bioinformatics solution for antibody discovery, built on its Luma Scientific Intelligence Platform.
Geneious Luma is designed to streamline the process of biologic therapeutic discovery by integrating advanced sequence analysis, data management, and AI-powered automation. This release marks the first of several multimodal solutions aimed at transforming scientific research and accelerating the discovery of new therapies.
Thomas Swalla, CEO of Dotmatics, explained the benefit of Geneious Luma in a recent video interview with VentureBeat: “The problem we’re solving is that discovering new molecules and drugs has become increasingly complicated. It takes over a decade to bring a drug to market and costs anywhere from two to six billion dollars.”
Article
Here is a rewritten version of the text with more details:
Dotmatics, a software company founded in 1991, has been a pioneer in providing laboratory information management system (LIMS) and data management solutions for the life sciences industry.
The company's journey began with a team of scientists and software developers who recognized the need for a more efficient and effective way to manage laboratory data. Their first product, Dotmatics LIMS, was launched in 1994 and quickly gained popularity among pharmaceutical and biotechnology companies due to its ability to streamline laboratory operations, track samples, and analyze data.
Over the years, Dotmatics has continued to innovate and expand its product portfolio by acquiring several companies and developing new solutions to meet the evolving needs of the life sciences industry. Today, the company offers a range of software solutions that help life sciences organizations manage their laboratory data, streamline their workflows, and improve their overall efficiency.
At the heart of Dotmatics' offerings is its flagship product, Dotmatics LIMS, a comprehensive laboratory information management system that enables organizations to manage their laboratory operations, track samples, and analyze data. This solution provides a centralized platform for managing laboratory data, including sample tracking, data storage, and retrieval. Additionally, Dotmatics LIMS automates many laboratory workflows, reducing manual errors and increasing efficiency.
Beyond LIMS, Dotmatics offers a range of other solutions designed to meet the specific needs of life sciences organizations. These include:
The key features and benefits of Dotmatics' solutions include:
Overall, Dotmatics is a leading provider of laboratory information management system (LIMS) and data management solutions for the life sciences industry, helping organizations to manage their laboratory data, streamline their workflows, and improve their overall efficiency.